Details for Patent: 10,799,453

Which drugs does patent 10,799,453 protect, and when does it expire?

Patent 10,799,453 protects KATERZIA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 10,799,453

Title:	Amlodipine formulations
Abstract:	Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Inventor(s):	Scott BRAUER, Gerold L. Mosher
Assignee:	Azurity Pharmaceuticals Inc
Application Number:	US16/381,575
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,799,453
Patent Claim Types: see list of patent claims	Compound; Process;

Drugs Protected by US Patent 10,799,453

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Azurity	KATERZIA	amlodipine benzoate	SUSPENSION;ORAL	211340-001	Jul 8, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 10,799,453

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3096101
China	112334134
European Patent Office	3773574
Japan	2021520367
Japan	7456933